Two decades after the landmark Women's Health Initiative changed the way clinicians thought about hormone therapy and cancer, new findings suggest this national health study is"the gift that keeps on giving."
In one of the hormone therapy trials, 17,000 women with a uterus at baseline were randomized to combined equine estrogen plus medroxyprogesterone acetate, or placebo. In the other trial, about 11,000 women with prior hysterectomy were randomized to daily estrogen alone or placebo. Both trials were stopped early: the estrogen-only trial due to an increased stroke risk, and the combined therapy trial due to findings of increased breast cancer and cardiovascular risk.
"Twenty years ago, the Women's Health Initiative showed that hormone replacement therapy increases breast cancer risk, and everyone stopped taking HRT. And now people pushing back on it and saying wait a second – it was the estrogen plus progesterone that increased breast cancer, not estrogen alone. And now we've got these newer formulations.
"You can't give it to a person unless they have their uterus removed because we know it will cause uterine cancer if the uterus is in place. But if the uterus is removed, the feeling was that you can give estrogen alone. I think the new piece that is going to get everyone's attention is this signal for ovarian cancer."
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: bbchealth - 🏆 143. / 63 Read more »
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Source: ScienceAlert - 🏆 63. / 68 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: Medscape - 🏆 386. / 55 Read more »
Source: WebMD - 🏆 709. / 51 Read more »